FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely ethinylestradiol 5 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine 25 milligram and ibuprofen 200 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and metoprolol tartrate 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 100 microgram and liothyronine sodium 25 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1.5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 15 milligram and methyldopa 250 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely homatropine methylbromide 1.5 milligram and hydrocodone bitartrate 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 2.5 milligram and paracetamol 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluoxetine hydrochloride 25 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 2 milligram and estradiol 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.1 gram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 12.5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pyrimethamine 25 milligram and sulfadoxine 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 25 microgram and liothyronine sodium 6.25 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glipizide 5 milligram and metformin hydrochloride 500 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ibuprofen 400 milligram and oxycodone 5 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydralazine hydrochloride 100 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 50 microgram and liothyronine sodium 12.5 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely drospirenone 500 microgram and estradiol 1 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 12 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydralazine hydrochloride 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely eprosartan mesilate 600 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydralazine hydrochloride 50 milligram and hydrochlorothiazide 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely furosemide 40 milligram and triamterene 50 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely naproxen sodium 500 milligram and sumatriptan succinate 85 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely levothyroxine sodium 150 microgram and liothyronine sodium 37.5 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely furosemide 20 milligram and spironolactone 50 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 90 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil fumarate 136 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 660 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lopinavir 133.3 milligram and ritonavir 33.3 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely loratadine 10 milligram and pseudoephedrine sulfate 240 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 305 milligram and folic acid 350 microgram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluoxetine hydrochloride 50 milligram and olanzapine 6 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferrous fumarate 322 milligram and folic acid 350 microgram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrochlorothiazide 25 milligram and labetalol hydrochloride 300 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pethidine hydrochloride 50 milligram and promethazine hydrochloride 25 milligram/1 each conventional release oral capsule Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cyclophosphamide (as cyclophosphamide monohydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely aspirin DL-lysine 900 milligram and metoclopramide hydrochloride 10 milligram/1 sachet conventional release oral powder Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benorilate 2 gram/1 sachet granules for conventional release oral suspension Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely deferoxamine mesilate 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ampicillin (as ampicillin sodium) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ceftazidime (as ceftazidime pentahydrate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cefpirome (as cefpirome sulfate) 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ifosfamide 2 gram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dalfopristin (as dalfopristin mesilate) 350 milligram and quinupristin (as quinupristin mesilate) 150 milligram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely codeine phosphate 60 milligram and paracetamol 1 gram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely remifentanil (as remifentanil hydrochloride) 2 milligram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely metoclopramide hydrochloride 5 milligram and paracetamol 500 milligram/1 sachet effervescent powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely raltitrexed 2 milligram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ispaghula husk 3.5 gram and mebeverine hydrochloride 135 milligram/1 sachet granules for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely magnesium alginate 87.5 milligram and sodium alginate 225 milligram/1 sachet powder for conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely galactose 2.49 gram and palmitic acid 2.5 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely galactose 3.99 gram and palmitic acid 4 milligram/1 vial powder for conventional release suspension for injection Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mitomycin 2 milligram/1 vial powder for conventional release solution for injection Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 2
    Piperacillin 2g / Tazobactam 250mg powder for solution for infusion vials Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dantron 10 milligram/1 milliliter and docusate sodium 12 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dihydrocodeine tartrate 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 500 microgram/1 milliliter conventional release oral solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 100 microgram/1 milliliter conventional release oral solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydroxyzine hydrochloride 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely orciprenaline sulfate 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely diazepam 2 milligram/1 milliliter conventional release oral suspension Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely dantron 15 milligram/1 milliliter and poloxamer 188 200 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely diphenhydramine hydrochloride 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely sulfamethoxazole 80 milligram/1 milliliter and trimethoprim 16 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely prednisolone 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely paroxetine (as paroxetine hydrochloride) 2 milligram/1 milliliter conventional release oral suspension Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely dried aluminium hydroxide gel 120 milligram/1 milliliter and magnesium hydroxide 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ampicillin (as ampicillin trihydrate) 25 milligram/1 milliliter and flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely pholcodine 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dicycloverine hydrochloride 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely lopinavir 80 milligram/1 milliliter and ritonavir 20 milligram/1 milliliter conventional release oral solution Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous ointment Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely midazolam (as midazolam hydrochloride) 2 milligram/1 milliliter conventional release oral solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely clorquinaldol 30 milligram/1 gram and hydrocortisone butyrate 1 milligram/1 gram conventional release cutaneous cream Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1

    Start Previous Page 6 of 35 Next End

    This concept is not in any reference sets

    Back to Start